Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies (Q38634230)

5 September 2017

Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies (English)

1 reference

5 September 2017

39

Genevieve Bernard

1 reference

5 September 2017

41

Adeline Vanderver

1 reference

5 September 2017

Keith van Haren

40

0 references

Nicole I Wolf

object named as

Nicole I Wolf

36

0 references

Ayelet Zerem

37

object named as

Ayelet Zerem

1 reference

5 September 2017

Laura A Adang

1

1 reference

5 September 2017

Omar Sherbini

2

1 reference

5 September 2017

Laura Ball

3

1 reference

5 September 2017

Miriam Bloom

4

1 reference

5 September 2017

Anil Darbari

5

1 reference

5 September 2017

Hernan Amartino

6

1 reference

5 September 2017

Donna DiVito

7

1 reference

5 September 2017

Florian Eichler

8

1 reference

5 September 2017

Maria Escolar

9

1 reference

5 September 2017

Sarah H Evans

10

1 reference

5 September 2017

Ali Fatemi

11

1 reference

5 September 2017

Jamie Fraser

12

1 reference

5 September 2017

Leslie Hollowell

13

1 reference

5 September 2017

Nicole Jaffe

14

1 reference

5 September 2017

Christopher Joseph

15

1 reference

5 September 2017

Mary Karpinski

16

1 reference

5 September 2017

Stephanie Keller

17

1 reference

5 September 2017

Ryan Maddock

18

1 reference

5 September 2017

Edna Mancilla

19

1 reference

5 September 2017

Bruce McClary

20

1 reference

5 September 2017

Jana Mertz

21

1 reference

5 September 2017

Kiley Morgart

22

1 reference

5 September 2017

Thomas Langan

23

1 reference

5 September 2017

Richard Leventer

24

1 reference

5 September 2017

Sumit Parikh

25

1 reference

5 September 2017

Amy Pizzino

26

1 reference

5 September 2017

Erin Prange

27

1 reference

5 September 2017

Deborah L Renaud

28

1 reference

5 September 2017

William Rizzo

29

1 reference

5 September 2017

Jay Shapiro

30

1 reference

5 September 2017

Dean Suhr

31

1 reference

5 September 2017

Teryn Suhr

32

1 reference

5 September 2017

Davide Tonduti

33

1 reference

5 September 2017

Jacque Waggoner

34

1 reference

5 September 2017

Amy Waldman

35

1 reference

5 September 2017

Joshua L Bonkowsky

38

1 reference

5 September 2017

Global Leukodystrophy Initiative (GLIA) Consortium

42

1 reference

5 September 2017

20 August 2017

1 reference

Molecular Genetics and Metabolism

5 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

5 September 2017

1 reference

Consensus statement on preventive and symptomatic care of leukodystrophy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Metachromatic Leukodystrophy: An Assessment of Disease Burden.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

National variation in costs and mortality for leukodystrophy patients in US children's hospitals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Disease specific therapies in leukodystrophies and leukoencephalopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Determinants of health care use in a population-based leukodystrophy cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Clinical management of Krabbe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Preventable Infections in Children with Leukodystrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

The burden of inherited leukodystrophies in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Classification and definition of disorders causing hypertonia in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Leukodystrophies: classification, diagnosis, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

The PedsQL: measurement model for the pediatric quality of life inventory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Longitudinal assessment of adaptive behavior in infants and young children with newly diagnosed epilepsy: influences of etiology, syndrome, and seizure control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Pediatric tone management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Management of motor problems in cerebral palsy: a critical update for the clinician

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Nonoperative management of spasticity in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Intrathecal baclofen therapy in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Neurosurgical management of abnormal muscle tone in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Effect of selective dorsal rhizotomy on daily care and comfort in non-walking children and adolescents with severe spasticity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Selective dorsal rhizotomy: meta-analysis of three randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Single-Event Multilevel Surgery in Children with Spastic Diplegia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Perioperative complications and outcomes in children with cerebral palsy undergoing scoliosis surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Dystonia in childhood: clinical and objective measures and functional implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

A systematic review of the Tardieu Scale for the measurement of spasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Movement disorder-childhood rating scale: reliability and validity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Medical treatment of dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Treatment of generalized dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Special concerns in defining, studying, and treating dystonia in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

7 January 2021

Dystonia and dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Assessment and treatment of movement disorders in children with cerebral palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Intrathecal baclofen for generalized dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Fracture Prediction and the Definition of Osteoporosis in Children and Adolescents: The ISCD 2013 Pediatric Official Positions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Long-term bone density evaluation in cerebrotendinous xanthomatosis: evidence of improvement after chenodeoxycholic acid treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Bone health in children and adolescents with chronic diseases that may affect the skeleton: the 2013 ISCD Pediatric Official Positions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Bone mineral density in a population of children and adolescents with cerebral palsy and mental retardation with or without epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Revised pediatric reference data for the lateral distal femur measured by Hologic Discovery/Delphi dual-energy X-ray absorptiometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Clinical epidemiologic characterization of orthopaedic and neurological manifestations in children with leukodystrophies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Simultaneous progression patterns of scoliosis, pelvic obliquity, and hip subluxation/dislocation in non-ambulatory neuromuscular patients: an approach to deformity documentation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Windswept hip deformity in children with cerebral palsy: a population-based prospective follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Australian hip surveillance guidelines for children with cerebral palsy: 5-year review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Early-onset scoliosis: current treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Guidelines for management of scoliosis in Rett syndrome patients based on expert consensus and clinical evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Gross Motor Function Classification System: impact and utility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Development and reliability of a classification system for gross motor function in children with metachromatic leucodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Cutaneous histopathological findings of AicardiGoutires syndrome, overlap with chilblain lupus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Clinical approach to leukoencephalopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Salivary botulinum toxin injection may reduce aspiration pneumonia in neurologically impaired children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Managing children with sialorrhoea (drooling): Experience from the first 301 children in our saliva control clinic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Clinical practice: swallowing problems in cerebral palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Glycopyrrolate for chronic drooling in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Diagnosis and Management of Drooling in Children With Progressive Dystonia: A Case Series of Patients With MEGDEL Syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Intraoral application of atropine sulfate ophthalmic solution for clozapine-induced sialorrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Dietary Intakes and Nutritional Issues in Neurologically Impaired Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

The importance of good nutrition in children with cerebral palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Effects of augmentative and alternative communication intervention on speech production in children with autism: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Cerebral palsy: clinical care and neurological rehabilitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Gastroesophageal reflux disease in neonates and infants : when and how to treat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Effectiveness of Fundoplication or Gastrojejunal Feeding in Children With Neurologic Impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Impact of personalized feeding program in 100 NICU infants: pathophysiology-based approach for better outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Pediatric palliative care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Effect of gastrostomy on growth in children with neurodevelopmental disabilities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Fundoplication and gastrostomy versus percutaneous gastrojejunostomy for gastroesophageal reflux in children with neurologic impairment: A systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Assessment and management of nutrition and growth in Rett syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Early sucking and swallowing problems as predictors of neurodevelopmental outcome in children with neonatal brain injury: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Unintended Adverse Effects of Enteral Nutrition Support: Parental Perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Bristol Stool Chart: Prospective and monocentric study of "stools introspection" in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Digestive tract neural control and gastrointestinal disorders in cerebral palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Gallbladder abnormalities in children with metachromatic leukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Pathology of the gallbladder in a child with metachromatic leukodystrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Cerebrotendinous xanthomatosis: clinical and laboratory study of 2 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Abnormalities of acid-base balance and predisposition to metabolic acidosis in Metachromatic Leukodystrophy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Spinal muscular atrophy type 1: management and outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Augmentative and alternative communication for people with progressive neuromuscular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

The impact of augmentative and alternative communication intervention on the speech production of individuals with developmental disabilities: a research review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Phase 2 of CATALISE: a multinational and multidisciplinary Delphi consensus study of problems with language development: Terminology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Communication Services and Supports for Individuals With Severe Disabilities: Guidance for Assessment and Intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Outcome of recommendations for augmentative communication in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

A systematic review of treatment outcomes for children with childhood apraxia of speech.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Locked-in: the syndrome as depicted in literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

A practice pathway for the identification, evaluation, and management of insomnia in children and adolescents with autism spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Pediatric palliative care for children with complex chronic medical conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Management of common neurologic symptoms in pediatric palliative care: seizures, agitation, and spasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Development of the World Health Organization Guidelines on Cancer Pain Relief and Palliative Care in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Epilepsy: mimics, borderland and chameleons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Genetic autonomic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Pediatric autonomic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

GFAP mutations, age at onset, and clinical subtypes in Alexander disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

A longitudinal study of a family with adult-onset autosomal dominant leukodystrophy: Clinical, autonomic and neuropsychological findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Clinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Clinical and molecular phenotype of Aicardi-Goutieres syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

Coronary heart disease in a patient with cerebrotendinous xanthomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.08.006

10.1016/J.YMGME.2017.08.006

7 January 2021

Identifiers

DOI

1 reference

5 September 2017

1 reference